Amoxicillin and amoxicillin plus clavulanate: A safety review

Expert Opinion on Drug Safety

Volumn 8, Issue 1, 2009, Pages 111-118

  Salvo, Francesco ^a   De Sarro, Angelina ^a   Caputi, Achille Patrizio ^a,b   Polimeni, Giovanni ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

lactams; Adverse drug reactions; Amoxicillin; Clavulanic acid

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; CLAVULANIC ACID; ERYTHROMYCIN; FLUCLOXACILLIN; PENICILLIN V; TETRACYCLINE; TICARCILLIN; TRIMETHOPRIM; WARFARIN;

ABDOMINAL CRAMP; ANTIBIOTIC RESISTANCE; BRONCHITIS; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; GROUP A STREPTOCOCCAL INFECTION; HEPATITIS; HUMAN; LIVER DISEASE; LIVER INJURY; NAUSEA; OTITIS MEDIA; PATIENT SAFETY; PREGNANT WOMAN; RESPIRATORY TRACT INFECTION; REVIEW; RISK; SINUSITIS; SKIN INFECTION; SKIN MANIFESTATION; SMALL INTESTINE DISEASE; SMALL INTESTINE MOTOR DISTURBANCE; SOFT TISSUE INFECTION; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; URINARY TRACT INFECTION; VOMITING;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLAVULANIC ACID; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 67649435998     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330802527984     Document Type: Review

References (98)

1. The World Health Report 2005. Make every mother and child count. World Health Organization. Geneva: WHO Press, 2005. Available from: http://www.who.int/entity/whr/2005/whr2005-en.pdf [Last accessed July 11 2008]
2. Sutherland R, Croydon EAP, Rolinson GN. Amoxycillin: a new semisynthetic penicillin. BMJ 1972;3:13-16
3. Hardman JG, Limbird LE. Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th edition). New York: McGraw-Hill Professional Publishing, 2001
4. McManus MC. Mechanisms of bacterial resistance to antimicrobial agents. Am J Health Syst Pharm 1997;54:1420-1433 (Pubitemid 27260181)
5. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-1233
6. Reading C, Cole M. Clavulanic acid: a beta-lactamase inhibiting betalactam from Streptomyces clavuligerus. Antimicrob Agents Chemother 1977;11:852-857 (Pubitemid 8119260)
7. Wright AJ. The penicillins. Mayo Clin Proc 1999;74:290-307 Published erratum appears in: Mayo Clin Proc 1999;74:1184
8. Finlay J, Miller L, Poupard JA. A review of the antimicrobial activity of clavulanate. J Antimicrob Chemother 2003;52:18-23 (Pubitemid 36850079)
9. Kerc J, Opara J. A new amoxicillin/clavulanate therapeutic system: preparation in vitro and pharmacokinetic evaluation. Int J Pharm 2007;335:106-113 (Pubitemid 46482868)
10. Felmingham D, Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander Project 1992-1996. J Chemother 1999;11S:S5-21
11. Marimón JM, Pérez-Trallero E, Ercibengoa M, et al. Molecular epidemiology and variants of the multidrug-resistant Streptococcus pneumoniae Spain14-5 international clone among Spanish clinical isolates. J Antimicrob Chemother 2006;57:654-660
12. GlaxoSmithKline. Prescribing information for Augmentin®. Available from: URL: http://www.augmentin.com [Accessed Jul 15 2008]
13. Todd PA, Benfield P. Amoxicillin/clavulanic acid: an update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1990;39:264-307 (Pubitemid 20092131)
14. Barr WH, Zola EM, Candler EL, et al. Differential absorption of amoxicillin from the human small and large intestine. Clin Pharmacol Ther 1994;56:279-285 (Pubitemid 24323919)
15. Torres-Molina F, Peris-Ribera JE, García-Carbonell MC, et al. Nonlinearities in amoxycillin pharmacokinetics I. Disposition studies in the rat. Biopharm Drug Dispos 1992;13:23-38
16. Torres-Molina F, Peris-Ribera JE, García-Carbonell MC, et al. Nonlinearities in amoxycillin pharmacokinetics II. Absorption studies in the rat. Biopharm Drug Dispos 1992;13:39-53
17. Nilsson-Ehle I, Fellner H, Hedström SA, et al. Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers. J Antimicrob Chemother 1985;16:491-498 (Pubitemid 15249081)
18. Jackson D, Cooper DL, Horton R, et al. Augmentin: absorption, excretion and pharmacokinetic studies in man. Postgrad Med 1984;76:51-70
19. Reed MD. The clinical pharmacology of amoxicillin and clavulanic acid. Pediatr Infect Dis J 1998;17:957-962 (Pubitemid 28506434)
20. Gálvez-Múgica MA, Frías-Iniesta J, Guerra P, et al. Comparative bioavailability of two oral 875/125mg sachet formulations of amoxicillin/clavulanic acid in healthy volunteers. Clin Drug Invest 1999;18:217-224 (Pubitemid 29457130)
21. Adam D, De Vissser I, Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother 1982;22:353-357 (Pubitemid 13241690)
22. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance. A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9 Published erratum appears in: Pediatr Infect Dis J 1999;18:341
23. Huchon GJ, Gialdroni-Grassi G, Leophonte P, et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996;9:1590-1595 (Pubitemid 26271137)
24. Selgrad M, Malfertheiner P. New strategies for Helicobacter pylori eradication. Curr Opin Pharmacol 2008; [Epub ahead of print]
25. Holten KB, Onusko EM. Appropriate prescribing of oral beta-lactam antibiotics. Am Fam Physician 2000;62:611-620 (Pubitemid 30643480)
26. Neu HC, Wilson APR, Gruneberg RN. Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992. J Chemother 1993;5:67-93
27. Martinez-Mir JM, Ferrer V, Palop L, et al. Are the adverse drug reactions of amoxicillin and amoxicillin-clavulanic acid similar? Pharmacoepidemiol Drug Saf 1996;5:247-254
28. Salvo F, Polimeni G, Moretti U, et al. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. J Antimicrob Chemother 2007;60:121-126 (Pubitemid 47078716)
29. Croydon P. Progress and perspectives on betalactamase inhibition in Postgraduate medicine: a review of Augmentin. Custom Communications New York; 1984. p. 71-78
30. Bax R. Development of a twice daily dosing regimen of amoxicillin/clavulanate. Int J Antimicrob Agents 2007;30:S118-21 (Pubitemid 350101126)
31. Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-1227 (Pubitemid 17156038)
32. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004;42:1203-1206 (Pubitemid 38332848)
33. Caron F, Ducrotte P, Lerebours E, et al. Effects of amoxicillin- clavulanate combination on the motility of the small intestine in human beings. Antimicrob Agents Chemother 1991;35:1085-1088
34. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007;25:1135-1151 (Pubitemid 46650295)
35. De Abajo FJ, Montero D, Madurga M, et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 2004;58:71-80 (Pubitemid 38901470)
36. Hussaini SH, O'Brien CS, Despott EJ, Dalton HR. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol 2007;19:15-20 (Pubitemid 46066863)
37. Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512-521 (Pubitemid 41096639)
38. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-455 (Pubitemid 34810366)
39. Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999;44:731-735 (Pubitemid 29195925)
40. van Den Broek JW, Buennemeyer BL, Stricker BH. Cholestatic hepatitis due to amoxicillin and clavulanic acid. Ned Tijdschr Geneeskd 1988;132:1495-1497 (Pubitemid 18202347)
41. Cundiff J, Joe S. Amoxicillin-clavulanic acid-induced hepatitis. Am J Otolaryngol 2007;28:28-30 (Pubitemid 44879655)
42. Garcia Rodriguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Int Med 1996;156:1327-1332 (Pubitemid 26196892)
43. Larrey D, Vial T, Micaleff A, et al. Hepatitis associated with amoxicillin-clavulanic acid combination: reports of 15 cases. Gut 1992;33:368-371
44. Madronero AB, Porcel JM, Bielsa S. Hepatotoxicity induced by amoxicillin. Rev Esp Enferm Dig 2007;99:173-174 (Pubitemid 350259860)
45. Fontana RJ, Obaid Shakil A, Greenson JK, et al. Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci 2005;50:1785-1790 (Pubitemid 41413891)
46. Schwarze C, Schmitz V, Fischer HP, et al. Vanishing bile duct syndrome associated with elevated pancreatic enzymes after short-term administration of amoxicillin. Eur J Gastroenterol Hepatol 2002;14:1275-1277 (Pubitemid 35471537)
47. Bolzan H, Spatola J, Castelletto R, Curciarello J. Intrahepatic cholestasis induced by amoxicillin alone. Gastroenterol Hepatol 2000;23:237-239 (Pubitemid 30497544)
48. Reddy RK, Brillant P, Shiffer ER. Amoxicillin-clavulanate potassium associated colestasis. Gatroenterology 1989;96:1135-1141
49. Berg P, Hahn EG. Hepatotoxic reactions induced by beta-lactamase inhibitors. Eur J Med Res 2001;6:535-542
50. Nathani MG, Mutchnick MG, Tynes MD, et al. An unusual case of amoxicillin/clavulanic acid-related hepatotoxicity. Am J Gastroenterol 1998;93:1363-1365 (Pubitemid 29076943)
51. van der Auwera P, Legrand JC. Ticarcillin clavulanic acid therapy in severe infections. Drugs Exp Clin Res 1985;11:805-813 (Pubitemid 16208428)
52. Stricker BH, van der Broek JWG, Keuning J, et al. Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin). Dig Dis Sci 1989;34:1576-1580 (Pubitemid 19255351)
53. Hautakeete ML, Brenard R, Hoesmans Y, et al. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 1995;22:71-77
54. Gresser U. Amoxicillin-clavulanic acid therapy may be associated with severe side effects-review of the literature. Eur J Med Res 2001;6:139-149
55. Zaidi SA. Hepatitis associated with amoxicillin/clavulanic acid and/or ciprofloxacin. Am J Med Sci 2003;325:31-33 (Pubitemid 36109686)
56. Lucena MI, Andrade RJ, Fernández MC, et al. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology 2006;44:850-856 (Pubitemid 46489548)
57. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-499 (Pubitemid 40861991)
58. Thomson JA, Fairley CK, Ugoni AM, et al. Risk factors for the development of amoxycillin-clavulanic acid associate jaundice. MJA 1995;162:638-640
59. Smith PM, Wilton A, Routledge PA. Jaundice associated with amoxicillin-clavulanate potassium therapy. Eur J Gastroenterol Hepatol 1991;3:95-96
60. Ersoz G, Karasu Z, Yildiz C, et al. Severe toxic hepatitis associated with amoxicillin and clavulanic acid. J Clin Pharm Ther 2001;26:225-229 (Pubitemid 32592554)
61. Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology 2006;44:1581-1588 (Pubitemid 44953663)
62. Hautekeete ML, Horsmans Y, van Waeyenberge C, et al. HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 1999;117:1181-1186 (Pubitemid 29512678)
63. Andrade RJ, Lucena MJ, Alonso A, et al. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 2004;39:1603-1612 (Pubitemid 38702661)
64. Lucena MI, Andrade RJ, Martinez C, et al. Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosynicratic drug-induced liver injury. Hepatology 2008;48:588-596
65. Patriarca G, Dámbrosio C, Schiavino D, Nucera E. Allergy to betalactams: relationship between chemical structure and antigenicity of molecules. J Investig Allergol Clin Immunol 1999;9:215-221 (Pubitemid 29447476)
66. Cayen YD, Wuthrich B. Drug allergy to the b-lactam antibiotics clavulanic acid and amoxicillin. Allergy 1997;52:117-118 (Pubitemid 27120639)
67. Blanca M, Majorga C, Torres MJ, et al. Side-chain-specific specific reactions to beta-lactams: 14 years later. Clin Exp Allergy 2002;32:192-197 (Pubitemid 34429596)
68. Edwards RG, Dewdney JM, Dobrzanski RJ, Lee D. Immunogenicity and allergenicity studies on two betalactam structures, a clavam, clavulanic acid, and carbapenem: structure-activity relationships. Int Arch Allergy Appl Immunol 1988;85:184-189 (Pubitemid 18061126)
69. Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839-846
70. van der Linden PD, van der Lei J, Vlug AE, Stricker BH. Skin reactions to antimicrobial agents in general practice. J Clin Epidemiol 1998;51:703-708 (Pubitemid 28404365)
71. Limauro DL, Chan-Tompkins NH, Carter RW, et al. Amoxicillin/clavulanate- associated hepatic failure with progression to Stevens-Johnson syndrome. Ann Pharmacother 1999;33:560-564 (Pubitemid 29255064)
72. Easton J, Noble S, Perry CM. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media. Drugs 2003;63:311-340 (Pubitemid 36197502)
73. Turck D, Bernet JP, Marx J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003;37:22-26 (Pubitemid 39274563)
74. Davydov L, Yermolnik M, Cuni L. Warfarin and amoxicillin/clavulanate drug interaction. Ann Pharmacother 2003;37:367-370 (Pubitemid 36249635)
75. Wood G, Deeble T. Warfarin: dangers with antibiotics. Dent Update 1993;20:350-353
76. Kelly M, Moran J, Byrne S. Formation of rectus sheath hematoma with antibiotic use and warfarin therapy: a case report. Am J Geriatr Pharmacother 2005;3:266-269 (Pubitemid 43264604)
77. De Vigan C, De Walle HE, Cordier S, et al. Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational exposures and congenital anomalies. J Clin Epidemiol 1999;52:977-982
78. Berkovitch M, Diav-Citrin O, Greenberg R, et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 2004;58:298-302 (Pubitemid 39209063)
79. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 2001;97:188-192 (Pubitemid 32645654)
80. Friedman JM, Polifka JE. Teratogenic Effects of Drugs. A Resource for Clinicians (TERIS). Baltimore (USA), The Johns Hopkins University Press; 2000. p. 149-195
81. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006;107:1120-1138 (Pubitemid 43755551)
82. Committee on Drugs, American Academy of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-789
83. Guillemot D, Bonacorsi S, Blanchard JS, et al. Amoxicillin-clavulanate therapy increases childhood nasal colonization by methicillin-susceptible staphylococcus aureus strains producing high levels of penicillinase. Antimicrob Agents Chemother 2004;48:4618-4623 (Pubitemid 39577662)
84. Crémieux AC, Muller-Serieys C, Panhard X, et al. Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments. Antimicrob Agents Chemother 2003;47:2030-2035 (Pubitemid 36637840)
85. McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003;9:432-437
86. Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J Gen Intern Med 2005;20:697-702
87. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA 2001;286:1181-1186
88. Mazzaglia G, Caputi AP, Rossi A, et al. Exploring patient- and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care. Eur J Clin Pharmacol 2003;59:651-657 (Pubitemid 37494534)
89. Ioannidis JP, Contopoulos-Ioannidis DG, Chew P, Lau J. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother 2001;48:677-689 (Pubitemid 33100314)
90. de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ 1998;317:632-637 (Pubitemid 28403489)
91. de Bock GH, Dekker FW, Stolk J, et al. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol 1997;50:881-890 (Pubitemid 27423517)
92. Rosenstein N, Phillips WR, Gerber MA, et al. The common cold - pinciples of judicious use of microbial agents. Pediatrics 1998;S101:S181-4
93. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001;134:518-520 (Pubitemid 32225956)
94. Damoiseaux RA, van Balen FA, Hoes AW, de Melker RA. Antibiotic treatment of acute otitis media in children under two years of age: evidence based? Br J Gen Pract 1998;48:1861-1864 (Pubitemid 28552147)
95. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;33:757-762 (Pubitemid 32831830)
96. Smucny JJ, Becker LA, Glazier RH, McIsaac W. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998;47:453-460 (Pubitemid 29011125)
97. Munck AP, Gahrn-Hansen B, Sogaard P, Sogaard J. Long-lasting improvement in general practitioners' prescribing of antibiotics by means of medical audit. Scand J Prim Health Care 1999;17:185-190 (Pubitemid 29491357)
98. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ 2004;329:431 (Pubitemid 39141477)